相关实验视频

Updated: May 21, 2025

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

针对Gli途径的Co(iii) 希夫基复合物抑制了基细胞癌细胞的迁移

Caroline E Bond¹, Keaton D Olson¹, Metehan Punar¹

¹Departments of Chemistry, Molecular Biosciences, Neurobiology, and Radiology, Northwestern University Evanston IL USA tmeade@northwestern.edu.

|March 20, 2025

概括

一种新的化合物CoGli-GOPEI有效地抑制基底细胞癌 (BCC) 细胞迁移,为手术提供了一个有希望的,不那么侵入性的治疗替代方案.

科学领域:

在瘤学瘤学.
生物化学生物化学
材料科学材料科学材料科学

背景情况:

基底细胞癌 (BCC) 是全球最常见的癌症,但治疗选择有限,通常涉及手术与化品副作用.
对BCC的非侵入性治疗有很大的需求.
针对刺信号通路,特别是Gli转录因子,是BCC治疗的关键策略.

研究的目的:

引入和评估一种新的过渡金属-DNA衍生物,CoGli-GOPEI,作为潜在的基底细胞癌 (BCC) 的非侵入性治疗剂.
为了比较CoGli-GOPEI在抑制BCC细胞迁移方面的有效性,与已建立的刺途径抑制剂相比.

主要方法:

开发一种新的过渡金属-DNA衍生物,CoGli-GOPEI.
在体外实验室实验中使用小鼠ASZ BCC细胞.
对 CoGli-GOPEI 与已知刺路径抑制剂 GANT-61 和 vismodegib 的比较分析.

主要成果:

在实验室实验中,CoGli-GOPEI在实验室实验中显示出对小鼠ASZ BCC细胞迁移的显著抑制.
该化合物在抑制细胞迁移方面超过了两种已知的刺路径抑制剂GANT-61和vismodegib.
这些发现表明CoGli-GOPEI作为一种新的治疗策略的潜力.

结论:

通过抑制癌细胞迁移,CoGli-GOPEI代表了基底细胞癌 (BCC) 的有前途的新型治疗剂.
刺鼠通路内准Gli转录因子为开发少入侵的BCC治疗提供了一个可行的策略.
CoGli-GOPEI的开发可能会导致癌症的传播减少,副作用比传统疗法少.

更多相关视频

Characterization of the Effects of Migrastatic Inhibitors on 3D Tumor Spheroid Invasion by High-resolution Confocal Microscopy

Characterization of the Effects of Migrastatic Inhibitors on 3D Tumor Spheroid Invasion by High-resolution Confocal Microscopy

Published on: September 16, 2019

A Novel In Vitro Wound Healing Assay to Evaluate Cell Migration

A Novel In Vitro Wound Healing Assay to Evaluate Cell Migration

Published on: March 17, 2018

相关概念视频

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

Cancer Cell Migration through Invadopodia

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...

The Intrinsic Apoptotic Pathway

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...